Shareholder Portal

Use the shareholder portal to tailor information from ViroGates to your preferences, see your shareholding and register for general meetings, appoint a proxy and much more.

To be able to send out information to Shareholders about ViroGates electronically, we would like to have your email address.
We will not use it for other purposes nor distribute it elsewhere. Please go to the shareholder portal to accept electronic communication by clicking the green button below (Go To Shareholder Portal)

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates